Geneos Wealth Management Inc. Alkermes Plc. Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 52 shares of ALKS stock, worth $1,621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 52
-0.0%
Holding current value
$1,621
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$908 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$592 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$405 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$395 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$286 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.12B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...